WO2022018352A1 - Procede ameliore de synthese de mercaptans fonctionnalises - Google Patents
Procede ameliore de synthese de mercaptans fonctionnalises Download PDFInfo
- Publication number
- WO2022018352A1 WO2022018352A1 PCT/FR2021/051300 FR2021051300W WO2022018352A1 WO 2022018352 A1 WO2022018352 A1 WO 2022018352A1 FR 2021051300 W FR2021051300 W FR 2021051300W WO 2022018352 A1 WO2022018352 A1 WO 2022018352A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- homoserine
- formula
- compound
- sulfhydrylase
- chosen
- Prior art date
Links
- 238000000034 method Methods 0.000 title claims abstract description 48
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical class S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 title abstract description 24
- 229910052760 oxygen Inorganic materials 0.000 claims abstract description 40
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims abstract description 39
- 239000001301 oxygen Substances 0.000 claims abstract description 39
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 27
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims abstract description 23
- 229920006395 saturated elastomer Polymers 0.000 claims abstract description 21
- 125000003118 aryl group Chemical group 0.000 claims abstract description 20
- 239000000203 mixture Substances 0.000 claims abstract description 15
- 125000005842 heteroatom Chemical group 0.000 claims abstract description 13
- 229910052799 carbon Inorganic materials 0.000 claims abstract description 4
- 150000001875 compounds Chemical class 0.000 claims description 75
- 239000011541 reaction mixture Substances 0.000 claims description 41
- FCXZBWSIAGGPCB-YFKPBYRVSA-N O-acetyl-L-homoserine Chemical compound CC(=O)OCC[C@H]([NH3+])C([O-])=O FCXZBWSIAGGPCB-YFKPBYRVSA-N 0.000 claims description 39
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 230000008569 process Effects 0.000 claims description 30
- FFFHZYDWPBMWHY-VKHMYHEASA-N L-homocysteine Chemical compound OC(=O)[C@@H](N)CCS FFFHZYDWPBMWHY-VKHMYHEASA-N 0.000 claims description 27
- 108090000790 Enzymes Proteins 0.000 claims description 25
- 102000004190 Enzymes Human genes 0.000 claims description 25
- FFFHZYDWPBMWHY-UHFFFAOYSA-N L-Homocysteine Natural products OC(=O)C(N)CCS FFFHZYDWPBMWHY-UHFFFAOYSA-N 0.000 claims description 24
- 230000015572 biosynthetic process Effects 0.000 claims description 24
- LSDPWZHWYPCBBB-UHFFFAOYSA-N Methanethiol Chemical compound SC LSDPWZHWYPCBBB-UHFFFAOYSA-N 0.000 claims description 23
- 238000003786 synthesis reaction Methods 0.000 claims description 23
- 150000003839 salts Chemical class 0.000 claims description 19
- UCKMPCXJQFINFW-UHFFFAOYSA-N Sulphide Chemical compound [S-2] UCKMPCXJQFINFW-UHFFFAOYSA-N 0.000 claims description 15
- 125000004122 cyclic group Chemical group 0.000 claims description 15
- -1 sulfide salt Chemical class 0.000 claims description 14
- 101710198496 O-acetyl-L-homoserine sulfhydrylase Proteins 0.000 claims description 11
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 claims description 8
- FXDNYOANAXWZHG-VKHMYHEASA-N O-phospho-L-homoserine Chemical compound OC(=O)[C@@H](N)CCOP(O)(O)=O FXDNYOANAXWZHG-VKHMYHEASA-N 0.000 claims description 8
- FXDNYOANAXWZHG-UHFFFAOYSA-N O-phospho-L-homoserine Natural products OC(=O)C(N)CCOP(O)(O)=O FXDNYOANAXWZHG-UHFFFAOYSA-N 0.000 claims description 8
- 239000003513 alkali Substances 0.000 claims description 8
- 239000007792 gaseous phase Substances 0.000 claims description 8
- 239000012429 reaction media Substances 0.000 claims description 7
- 229910052784 alkaline earth metal Inorganic materials 0.000 claims description 5
- 238000000926 separation method Methods 0.000 claims description 5
- HIVLDXAAFGCOFU-UHFFFAOYSA-N ammonium hydrosulfide Chemical compound [NH4+].[SH-] HIVLDXAAFGCOFU-UHFFFAOYSA-N 0.000 claims description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 3
- 108090000992 Transferases Proteins 0.000 claims description 3
- 102000004357 Transferases Human genes 0.000 claims description 3
- 229910052977 alkali metal sulfide Inorganic materials 0.000 claims description 3
- 238000010511 deprotection reaction Methods 0.000 claims description 3
- 238000007306 functionalization reaction Methods 0.000 claims description 3
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 5
- 150000004763 sulfides Chemical class 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 3
- 150000003568 thioethers Chemical class 0.000 description 39
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 23
- 210000004027 cell Anatomy 0.000 description 22
- 229960001153 serine Drugs 0.000 description 20
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 18
- UKAUYVFTDYCKQA-VKHMYHEASA-N L-homoserine Chemical compound OC(=O)[C@@H](N)CCO UKAUYVFTDYCKQA-VKHMYHEASA-N 0.000 description 16
- 150000002430 hydrocarbons Chemical group 0.000 description 16
- 239000000243 solution Substances 0.000 description 16
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 15
- 229920001021 polysulfide Polymers 0.000 description 14
- 239000002585 base Substances 0.000 description 13
- NGVDGCNFYWLIFO-UHFFFAOYSA-N pyridoxal 5'-phosphate Chemical compound CC1=NC=C(COP(O)(O)=O)C(C=O)=C1O NGVDGCNFYWLIFO-UHFFFAOYSA-N 0.000 description 13
- 239000007789 gas Substances 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
- 238000004519 manufacturing process Methods 0.000 description 9
- 235000007682 pyridoxal 5'-phosphate Nutrition 0.000 description 9
- 239000011589 pyridoxal 5'-phosphate Substances 0.000 description 9
- 239000000376 reactant Substances 0.000 description 9
- 239000002904 solvent Substances 0.000 description 9
- UKAUYVFTDYCKQA-UHFFFAOYSA-N -2-Amino-4-hydroxybutanoic acid Natural products OC(=O)C(N)CCO UKAUYVFTDYCKQA-UHFFFAOYSA-N 0.000 description 8
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 8
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 8
- 229910052757 nitrogen Inorganic materials 0.000 description 8
- 239000002994 raw material Substances 0.000 description 8
- ZTVZLYBCZNMWCF-WDSKDSINSA-N L,L-homocystine zwitterion Chemical compound OC(=O)[C@@H](N)CCSSCC[C@H](N)C(O)=O ZTVZLYBCZNMWCF-WDSKDSINSA-N 0.000 description 7
- 239000007864 aqueous solution Substances 0.000 description 7
- 238000007872 degassing Methods 0.000 description 7
- 239000007788 liquid Substances 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 5
- GNISQJGXJIDKDJ-YFKPBYRVSA-N O-succinyl-L-homoserine Chemical compound OC(=O)[C@@H](N)CCOC(=O)CCC(O)=O GNISQJGXJIDKDJ-YFKPBYRVSA-N 0.000 description 5
- 235000011114 ammonium hydroxide Nutrition 0.000 description 5
- 239000006227 byproduct Substances 0.000 description 5
- 230000003197 catalytic effect Effects 0.000 description 5
- 238000000855 fermentation Methods 0.000 description 5
- 230000004151 fermentation Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonium chloride Substances [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 4
- 229910052786 argon Inorganic materials 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 229910001873 dinitrogen Inorganic materials 0.000 description 4
- 239000011261 inert gas Substances 0.000 description 4
- 239000012071 phase Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- 230000000750 progressive effect Effects 0.000 description 4
- 229960001327 pyridoxal phosphate Drugs 0.000 description 4
- XRMDCWJNPDVAFI-UHFFFAOYSA-N 2,2,6,6-tetramethyl-1-oxopiperidin-1-ium-4-ol Chemical compound CC1(C)CC(O)CC(C)(C)[N+]1=O XRMDCWJNPDVAFI-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 3
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 3
- 229930006000 Sucrose Natural products 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 230000005587 bubbling Effects 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000007796 conventional method Methods 0.000 description 3
- 150000004683 dihydrates Chemical class 0.000 description 3
- 230000008034 disappearance Effects 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000012467 final product Substances 0.000 description 3
- 239000011521 glass Substances 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000004128 high performance liquid chromatography Methods 0.000 description 3
- 238000010907 mechanical stirring Methods 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 235000013379 molasses Nutrition 0.000 description 3
- 239000007787 solid Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000005720 sucrose Substances 0.000 description 3
- 229910052717 sulfur Inorganic materials 0.000 description 3
- MBEPFGPQVBIIES-UHFFFAOYSA-N 2-amino-4-(3-amino-3-carboxypropyl)sulfanylbutanoic acid Chemical compound OC(=O)C(N)CCSCCC(N)C(O)=O MBEPFGPQVBIIES-UHFFFAOYSA-N 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 241000194110 Bacillus sp. (in: Bacteria) Species 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000238631 Hexapoda Species 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- MKWKNSIESPFAQN-UHFFFAOYSA-N N-cyclohexyl-2-aminoethanesulfonic acid Chemical compound OS(=O)(=O)CCNC1CCCCC1 MKWKNSIESPFAQN-UHFFFAOYSA-N 0.000 description 2
- 238000005481 NMR spectroscopy Methods 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241001136494 Talaromyces funiculosus Species 0.000 description 2
- 241000499912 Trichoderma reesei Species 0.000 description 2
- ZGSDJMADBJCNPN-UHFFFAOYSA-N [S-][NH3+] Chemical compound [S-][NH3+] ZGSDJMADBJCNPN-UHFFFAOYSA-N 0.000 description 2
- 230000021736 acetylation Effects 0.000 description 2
- 238000006640 acetylation reaction Methods 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000000287 crude extract Substances 0.000 description 2
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 2
- 235000018417 cysteine Nutrition 0.000 description 2
- 238000004821 distillation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- ZTVZLYBCZNMWCF-UHFFFAOYSA-N homocystine Chemical compound [O-]C(=O)C([NH3+])CCSSCCC([NH3+])C([O-])=O ZTVZLYBCZNMWCF-UHFFFAOYSA-N 0.000 description 2
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 2
- RWSOTUBLDIXVET-UHFFFAOYSA-M hydrosulfide Chemical compound [SH-] RWSOTUBLDIXVET-UHFFFAOYSA-M 0.000 description 2
- 239000006166 lysate Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- DPLVEEXVKBWGHE-UHFFFAOYSA-N potassium sulfide Chemical compound [S-2].[K+].[K+] DPLVEEXVKBWGHE-UHFFFAOYSA-N 0.000 description 2
- 238000004313 potentiometry Methods 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- GRVFOGOEDUUMBP-UHFFFAOYSA-N sodium sulfide (anhydrous) Chemical compound [Na+].[Na+].[S-2] GRVFOGOEDUUMBP-UHFFFAOYSA-N 0.000 description 2
- 238000006467 substitution reaction Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- OJQQRWWUNXTWER-UHFFFAOYSA-N (4-formyl-5-hydroxy-6-methylpyridin-3-yl)methyl hydrogen sulfate Chemical compound CC1=NC=C(COS(O)(=O)=O)C(C=O)=C1O OJQQRWWUNXTWER-UHFFFAOYSA-N 0.000 description 1
- RBORURQQJIQWBS-QVRNUERCSA-N (4ar,6r,7r,7as)-6-(6-amino-8-bromopurin-9-yl)-2-hydroxy-2-sulfanylidene-4a,6,7,7a-tetrahydro-4h-furo[3,2-d][1,3,2]dioxaphosphinin-7-ol Chemical compound C([C@H]1O2)OP(O)(=S)O[C@H]1[C@@H](O)[C@@H]2N1C(N=CN=C2N)=C2N=C1Br RBORURQQJIQWBS-QVRNUERCSA-N 0.000 description 1
- ZNUHALOUHXORHZ-UHFFFAOYSA-N 1-(4-formyl-5-hydroxy-6-methylpyridin-3-yl)ethyl dihydrogen phosphate Chemical compound OP(=O)(O)OC(C)C1=CN=C(C)C(O)=C1C=O ZNUHALOUHXORHZ-UHFFFAOYSA-N 0.000 description 1
- JKMHFZQWWAIEOD-UHFFFAOYSA-N 2-[4-(2-hydroxyethyl)piperazin-1-yl]ethanesulfonic acid Chemical compound OCC[NH+]1CCN(CCS([O-])(=O)=O)CC1 JKMHFZQWWAIEOD-UHFFFAOYSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- OVNQVGRYGGPFDH-UHFFFAOYSA-N 3-(4-formyl-5-hydroxy-6-methylpyridin-3-yl)propanoic acid Chemical compound CC1=NC=C(CCC(O)=O)C(C=O)=C1O OVNQVGRYGGPFDH-UHFFFAOYSA-N 0.000 description 1
- USFZMSVCRYTOJT-UHFFFAOYSA-N Ammonium acetate Chemical compound N.CC(O)=O USFZMSVCRYTOJT-UHFFFAOYSA-N 0.000 description 1
- 239000005695 Ammonium acetate Substances 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 102100021935 C-C motif chemokine 26 Human genes 0.000 description 1
- FGUUSXIOTUKUDN-IBGZPJMESA-N C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 Chemical compound C1(=CC=CC=C1)N1C2=C(NC([C@H](C1)NC=1OC(=NN=1)C1=CC=CC=C1)=O)C=CC=C2 FGUUSXIOTUKUDN-IBGZPJMESA-N 0.000 description 1
- 239000008000 CHES buffer Substances 0.000 description 1
- AGVJBLHVMNHENQ-UHFFFAOYSA-N Calcium sulfide Chemical compound [S-2].[Ca+2] AGVJBLHVMNHENQ-UHFFFAOYSA-N 0.000 description 1
- 239000004215 Carbon black (E152) Substances 0.000 description 1
- 241000941525 Chromobacterium sp. Species 0.000 description 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- 108030002503 EC nomenclature Proteins 0.000 description 1
- 102000007458 EC nomenclature Human genes 0.000 description 1
- 241001198387 Escherichia coli BL21(DE3) Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 239000007995 HEPES buffer Substances 0.000 description 1
- 101000897493 Homo sapiens C-C motif chemokine 26 Proteins 0.000 description 1
- 101710083973 Homocysteine synthase Proteins 0.000 description 1
- 241000862985 Hyphomonas sp. Species 0.000 description 1
- 239000004201 L-cysteine Substances 0.000 description 1
- 235000013878 L-cysteine Nutrition 0.000 description 1
- MBEPFGPQVBIIES-WDSKDSINSA-N L-homolanthionine Chemical compound OC(=O)[C@@H](N)CCSCC[C@H](N)C(O)=O MBEPFGPQVBIIES-WDSKDSINSA-N 0.000 description 1
- 150000008550 L-serines Chemical class 0.000 description 1
- 241000589924 Leptospira sp. Species 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- JJIHLJJYMXLCOY-UHFFFAOYSA-N N-acetyl-DL-serine Natural products CC(=O)NC(CO)C(O)=O JJIHLJJYMXLCOY-UHFFFAOYSA-N 0.000 description 1
- JJIHLJJYMXLCOY-BYPYZUCNSA-N N-acetyl-L-serine Chemical compound CC(=O)N[C@@H](CO)C(O)=O JJIHLJJYMXLCOY-BYPYZUCNSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- 108010061618 O-succinylhomoserine (thiol)-lyase Proteins 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000001336 alkenes Chemical class 0.000 description 1
- 125000000217 alkyl group Chemical group 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229940093740 amino acid and derivative Drugs 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-N ammonia Natural products N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 1
- 229940043376 ammonium acetate Drugs 0.000 description 1
- 235000019257 ammonium acetate Nutrition 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- UYJXRRSPUVSSMN-UHFFFAOYSA-P ammonium sulfide Chemical compound [NH4+].[NH4+].[S-2] UYJXRRSPUVSSMN-UHFFFAOYSA-P 0.000 description 1
- 239000001166 ammonium sulphate Substances 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 125000004429 atom Chemical group 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 229910052790 beryllium Inorganic materials 0.000 description 1
- ATBAMAFKBVZNFJ-UHFFFAOYSA-N beryllium atom Chemical compound [Be] ATBAMAFKBVZNFJ-UHFFFAOYSA-N 0.000 description 1
- 230000008236 biological pathway Effects 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 229910052792 caesium Inorganic materials 0.000 description 1
- TVFDJXOCXUVLDH-UHFFFAOYSA-N caesium atom Chemical compound [Cs] TVFDJXOCXUVLDH-UHFFFAOYSA-N 0.000 description 1
- JGIATAMCQXIDNZ-UHFFFAOYSA-N calcium sulfide Chemical compound [Ca]=S JGIATAMCQXIDNZ-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 239000013592 cell lysate Substances 0.000 description 1
- 230000006037 cell lysis Effects 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 229950006137 dexfosfoserine Drugs 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 229910001882 dioxygen Inorganic materials 0.000 description 1
- 238000001962 electrophoresis Methods 0.000 description 1
- 150000002118 epoxides Chemical class 0.000 description 1
- YTBUNSFVTYZYIN-UHFFFAOYSA-N ethane;piperazine Chemical compound CC.C1CNCCN1 YTBUNSFVTYZYIN-UHFFFAOYSA-N 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000004880 explosion Methods 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 230000002538 fungal effect Effects 0.000 description 1
- 238000002523 gelfiltration Methods 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- 229910052736 halogen Inorganic materials 0.000 description 1
- 150000002367 halogens Chemical class 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 239000000543 intermediate Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 238000006317 isomerization reaction Methods 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- JRZJOMJEPLMPRA-UHFFFAOYSA-N olefin Natural products CCCCCCCC=C JRZJOMJEPLMPRA-UHFFFAOYSA-N 0.000 description 1
- 150000005677 organic carbonates Chemical class 0.000 description 1
- 150000002894 organic compounds Chemical class 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000020477 pH reduction Effects 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- 239000008363 phosphate buffer Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 210000001236 prokaryotic cell Anatomy 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 229910052701 rubidium Inorganic materials 0.000 description 1
- IGLNJRXAVVLDKE-UHFFFAOYSA-N rubidium atom Chemical compound [Rb] IGLNJRXAVVLDKE-UHFFFAOYSA-N 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- 229930195734 saturated hydrocarbon Chemical group 0.000 description 1
- 238000010517 secondary reaction Methods 0.000 description 1
- 150000003355 serines Chemical class 0.000 description 1
- 238000007873 sieving Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 229910052979 sodium sulfide Inorganic materials 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 229910052712 strontium Inorganic materials 0.000 description 1
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 1
- 230000020155 sulfhydration Effects 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 238000001308 synthesis method Methods 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 238000010189 synthetic method Methods 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- 150000003573 thiols Chemical group 0.000 description 1
- 239000002341 toxic gas Substances 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 238000005199 ultracentrifugation Methods 0.000 description 1
- 229930195735 unsaturated hydrocarbon Natural products 0.000 description 1
- 238000009849 vacuum degassing Methods 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- 210000005253 yeast cell Anatomy 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/12—Methionine; Cysteine; Cystine
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C319/00—Preparation of thiols, sulfides, hydropolysulfides or polysulfides
- C07C319/02—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols
- C07C319/08—Preparation of thiols, sulfides, hydropolysulfides or polysulfides of thiols by replacement of hydroxy groups or etherified or esterified hydroxy groups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1085—Transferases (2.) transferring alkyl or aryl groups other than methyl groups (2.5)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P11/00—Preparation of sulfur-containing organic compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y205/00—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5)
- C12Y205/01—Transferases transferring alkyl or aryl groups, other than methyl groups (2.5) transferring alkyl or aryl groups, other than methyl groups (2.5.1)
- C12Y205/01049—O-acetylhomoserine aminocarboxypropyltransferase (2.5.1.49)
Definitions
- the present invention relates to a process for the synthesis of functionalized mercaptans, as well as a composition allowing in particular the implementation of this process.
- Mercaptans are used in many industrial fields and many synthetic methods are known such as the sulfhydration of alcohols, the catalytic or photochemical addition of hydrogen sulfide to unsaturated organic compounds or substitution using hydrogen sulfurized with halides, epoxides or organic carbonates.
- substitution by hydrogen sulphide requires often high temperatures and pressures and leads to undesired by-products of the olefin, ether, sulphide and/or polysulphide type.
- the catalytic or photochemical addition of hydrogen sulfide to unsaturated compounds is generally done under slightly milder conditions but also leads to numerous by-products formed by isomerization of the raw material, by non-regioselective addition or by double addition. leading to the production of sulphides and/or polysulphides.
- the present invention makes it possible in whole or in part to overcome the drawbacks of the prior methods.
- An objective of the present invention is to provide a process for the synthesis of an improved functionalized mercaptan, in particular having a yield and/or a selectivity equivalent or superior to the known processes.
- An object of the present invention is to provide a process for the synthesis of a functionalized mercaptan with negligible, or even zero, co-production of by-products, in particular of sulphides and/or polysulphides.
- the present inventors have discovered that the functionalized mercaptans of formula (I) as defined below, in particular L-homocysteine, could be advantageously synthesized by reaction between compounds of formula (II) and a sulphhydrate salt and or a sulfide salt (hereinafter referred to as “salt”) as defined below or of HS, in the presence of a sulfhydrylase enzyme; said reaction taking place essentially in the absence of oxygen, or even in the absence of oxygen.
- the present inventors have thus discovered a process for the synthesis of functionalized mercaptans of formula (I) making it possible to limit or even avoid the co-production of sulphides and/or polysulphides, in particular disulphides.
- the method according to the invention makes it possible to produce L-homocysteine while limiting or even avoiding the co-production of L-homocysteine and/or L-homocysteine sulphide (also called 4,4'-sulfanediylbis( 2-aminobutanoic acid) / L- homolanthionine).
- L-homocysteine and/or L-homocysteine sulphide also called 4,4'-sulfanediylbis( 2-aminobutanoic acid) / L- homolanthionine.
- L-homocysteine has the following formula:
- L-homocysteine sulfide has the following formula:
- L-homocystine has the following formula:
- the functionalized mercaptan of formula (I) obtained according to the process of the invention can be enantiomerically pure.
- the process according to the invention is also easy to implement industrially. It can be carried out in solution under mild temperature and pressure conditions.
- the use of salts advantageously makes it possible to avoid the manipulation of hydrogen sulphide, which is a toxic gas, by the operators.
- the yield obtained may be greater than or equal to 85%, preferably greater than or equal to 90%, for example between 90% and 100%, limits included.
- the process according to the invention makes it possible in particular to obtain a yield of 100%, i.e. an increase of almost 20% compared to the other processes.
- the present invention relates to a process for the synthesis of at least one functionalized mercaptan of general formula (I) below:
- Ri and R 7 are a hydrogen atom or a hydrocarbon chain, saturated or unsaturated, linear, branched or cyclic, aromatic or not, of 1 to 20 carbon atoms and possibly comprising one or more heteroatoms;
- R3 being a hydrogen atom or a hydrocarbon chain, saturated or unsaturated, linear, branched or cyclic, aromatic or not, of 1 to 20 carbon atoms and which may comprise one or more heteroatoms,
- -NR4R5, R4 and R 5 identical or different, being a hydrogen atom or a hydrocarbon chain, saturated or unsaturated, linear, branched or cyclic, aromatic or not, of 1 to 20 carbon atoms and possibly include one or more heteroatoms; n is equal to 1 or 2; and * represents an asymmetric carbon; said method comprising the steps of: a) providing at least one compound of general formula (II) below:
- R10, R11, R I2 and R13 being independently of each other chosen from:
- R 7 and R 8 identical or different, being a proton, an alkali, an alkaline earth or an ammonium;
- R 9 is chosen from a proton, an alkali, an alkaline earth or an ammonium; b) supply of at least one sulphide salt and/or one sulphide or H 2 S salt; c) reaction between said at least one compound of formula (II) and said at least one sulfhydrate and/or sulfide salt or H 2 S in the presence of at least one enzyme chosen from sulfhydrylases, and preferably a sulfhydrylase associated with said compound of formula (II); said reaction being carried out essentially in the absence of oxygen, preferably in the absence of oxygen; d) obtaining at least one functionalized mercaptan of formula (I); e) optional separation of said at least one functionalized mercaptan of formula (I) obtained in step d); and f) optional additional functionalization and/or optional deprotection of the functionalized mercaptan of formula (I) obtained in step d) or e); and wherein steps a) and b) are
- Oxygen is understood in particular to mean dioxygen 0 2 .
- Step c) is thus carried out essentially in the absence of oxygen, or even in the absence of oxygen.
- the term “essentially in the absence of oxygen” means that there may remain a quantity of oxygen in the reaction mixture and/or in the gaseous phase (contained in the gas headspace of the reactor) such that the quantity of sulphides and/or polysulphides produced is less than or equal to 5% by weight relative to the total weight of the compound of formula (I) produced.
- the term “essentially in the absence of oxygen” preferably means that the reaction mixture contains less than 0.0015% oxygen (preferably strictly less than 0.0015%) by weight relative to the total weight of the reaction mixture and /or that the gaseous phase (contained in the gaseous headspace of the reactor) contains less than 21% oxygen (preferably strictly less than 21%) by volume relative to the total volume of said gaseous phase.
- step c) may alternatively be the following: c) reaction between said at least one compound of formula (II) and said at least one hydrosulphide and/or sulphide salt or H 2 S in the presence of at least one at least one enzyme chosen from sulfhydrylases, and preferably a sulfhydrylase associated with said compound of formula (II); said reaction taking place in a reactor in which the reaction mixture comprises between 0 and 0.0015% oxygen (preferably strictly less than 0.0015%) by weight relative to the total weight of the reaction mixture and/or the phase gas contained in the gas headspace of the reactor comprises between 0 and 21% oxygen (preferably strictly less than 21%) by volume relative to the total volume of the gas phase.
- the reaction mixture comprises between 0 and 0.0015% oxygen (preferably strictly less than 0.0015%) by weight relative to the total weight of the reaction mixture and/or the phase gas contained in the gas headspace of the reactor comprises between 0 and 21% oxygen (preferably strictly less than 21%) by volume relative to the total volume of the gas phase.
- the quantity of oxygen in the reaction mixture and/or in the gaseous phase is such that the quantity of sulphides and or polysulphides produced is less than or equal to 5% by weight relative to the total weight of the compound of formula (I) produced.
- step c) can be carried out in a closed reactor (i.e. without supplying oxygen from the air).
- the gaseous phase (contained in the gaseous headspace) does not include oxygen, in particular when HS is used.
- the gaseous phase (contained in the gas headspace) does not comprise oxygen and the reaction mixture comprises between 0 and 0.0015% oxygen (preferably strictly less than 0.0015%) by weight relative to the total weight of the reaction mixture.
- gas overhead means the space of the reactor located above the reaction mixture, preferably above the liquid reaction mixture. More specifically, the term “gas overhead” means the space located between the surface of the liquid reaction mixture and the top of the reactor (i.e. the upper part of the reactor comprising the gas phase when the lower part of the reactor comprises a liquid phase).
- the gas overhead comprises in particular a gas phase.
- the reactants are in particular introduced into the reactor in quantities such that a gaseous blanket is located above the reaction mixture contained in the reactor.
- reaction mixture may thus comprise: at least one compound of formula (II) as defined below, at least one sulphide and/or sulphide salt as defined below or H 2 S, at least one sulfhydrylase as defined below, optionally its cofactor as defined below, optionally a base as defined below, and optionally a solvent, preferably water.
- Said reaction mixture can be prepared by adding said compound of formula (II), said sulphhydrate and/or sulphide salt or H 2 S and said sulphydrylase in any order.
- the compound of formula (II) is in the form of a solution, more preferably in the form of an aqueous solution.
- sulphhydrate and/or sulphide salts are used in the form of a solution and more preferably in the form of an aqueous solution.
- HS sulphhydrate and/or sulphide salts
- it is generally in gaseous form. It can in particular be introduced into the reaction mixture by bubbling. The bubbling can be carried out by mixing the H 2 S with an inert gas, for example dinitrogen, argon or methane, preferably dinitrogen.
- the H 2 S can therefore be present in dissolved form in the reaction mixture.
- step c) In order to carry out step c) essentially in the absence of oxygen, or even in the absence of oxygen, conventional methods can be used.
- the oxygen is removed from the reaction mixture, for example by degassing.
- the oxygen is separately removed from each of the components or from the mixture of at least two of them which will form the reaction mixture.
- each of the solutions comprising the compound of formula (II), the sulfhydrate and/or sulfide salt when the latter is used, the sulfhydrylase and optionally the solvent is degassed.
- step c it is also possible to remove the oxygen from the top of the reactor in which step c takes place), preferably by degassing.
- the reactor can also be inerted with an inert gas such as nitrogen, argon or methane, preferably nitrogen.
- an inert gas such as nitrogen, argon or methane, preferably nitrogen.
- H 2 S which is gaseous
- degassing is of course not carried out for this reagent.
- H 2 S generally does not include oxygen.
- the absence of oxygen is obtained in the following way:
- the reactor is inert with an inert gas such as nitrogen, argon or methane, preferably nitrogen; and
- step c) the oxygen is present neither in dissolved form in a liquid (in particular in the reaction mixture), nor in gaseous form (in particular in the top of the reactor in which perform step c)).
- an inert gas e.g. argon, dinitrogen or methane.
- the sulphide salt and/or the sulphide salt or the H S is in excess, preferably in molar excess, relative to the compound of formula (II), preferably during step c) and more preferentially throughout the duration of step c).
- the hydrosulfide and/or sulfide salt or the H 2 S can therefore be in an over-stoichiometric quantity with respect to the quantity of the compound of formula (II), preferably during step c) and more preferably throughout the duration of step c).
- the [sulfhydrate salt and/or sulfide salt]/[compound of formula (II)] molar ratio or the H 2 S/compound of formula (II) molar ratio is between 1.5 and 10, preferably between 2 and 8, for example between 3.5 and 8, and even more preferably between 3.5 and 5, limits included, preferably during step c) and more preferably throughout the duration of step c). Said ratio can be kept constant throughout the duration of step c).
- Step c) can be carried out in solution, in particular in aqueous solution.
- the solution comprises between 50% and 99% by weight of water, preferably between 75% and 97% by weight of water relative to the total weight of the solution, limits included.
- the pH of the reaction mixture in step c) can be between 4 and 9, for example between 5 and 8, preferably between 6 and 7.5, and more particularly between 6.2 and 7.2, limits included, particularly when the reaction mixture is an aqueous solution.
- the pH can in particular be adjusted within the ranges mentioned above according to the optimum functioning of the sulfhydrylase chosen.
- the pH can be determined by conventionally known methods, for example with a pH-metric probe.
- step c) can be carried out according to the following two steps c1) and c2): c1) reaction between said at least one compound of formula (II) and said at least one sulphide salt and or sulphide or H 2 S in the presence of at least one enzyme chosen from sulfhydrylases, and preferably a sulfhydrylase associated with said compound of formula (II); said reaction being carried out essentially in the absence of oxygen, preferably in the absence of oxygen, and in solution; c2) adjustment of the pH of said solution by adding a base so as to obtain a pH of between 4 and 9, for example between 5 and 8, preferably between 6 and 7.5, and more particularly between 6.2 and 7.2, terminals included.
- any type of base can be used, preferably a base comprising a sulfur atom.
- base is meant in particular a compound or a mixture of compounds having a pH greater than 7, preferably between 8 and 14, limits included.
- the base can be chosen from salts of sulphides and/or salts of sulphides as defined below, sodium hydroxide, potassium hydroxide or aqueous ammonia.
- the base can be chosen from salts of sulphides and/or salts of sulphides as defined below.
- said base is the sulphide salt and/or the sulphide salt used in step c1).
- the preferred base is ammonium sulphhydrate (NH 4 SH).
- the base can be added at a concentration of between 0.1 and 10 M, preferably between 0.5 and 10 M, more preferably between 0.5 and 5 M, limits included.
- concentrated bases will be used so as to limit the dilution of the reaction mixture during the addition of the base.
- the temperature during step c) can be between 10°C and 60°C, preferably between 20°C and 40°C, and more particularly between 25°C and 40°C, limits included.
- the pressure during step c) is usually atmospheric pressure.
- Step c) can be carried out in batch, semi-continuous or continuous. Any type of reactor may be suitable.
- the separation step e) can be carried out according to any technique known to those skilled in the art.
- the final product when the final product is a solid: by extraction and/or decantation with a solvent that is immiscible in the reaction medium followed by evaporation of said solvent; by precipitation (by partial evaporation of the solvents or by addition of a solvent in which the compound of interest is less soluble).
- This precipitation is generally followed by a filtration step according to any method known to those skilled in the art.
- the final product can then be dried; or by selective precipitation by adjusting the pH and depending on the respective solubilities of the different compounds.
- Homocysteine can in particular be recovered in solid form.
- the separation can be carried out by distillation or by distillation or evaporation preceded by a liquid/liquid extraction.
- Step f) of additional functionalization and/or possible deprotection can make it possible to obtain additional chemical functions and/or to deprotect certain chemical functions by conventional methods.
- XR 2 represents a function carboxylic
- the latter can be esterified, reduced to aldehyde, reduced to alcohol and then estherified, amidified, nitrile or others. All the functions can be obtained and/or deprotected by those skilled in the art depending on the end use intended for said functionalized mercaptan of formula (I).
- the functionalized mercaptan of formula (I) obtained at the end of step d) or e) can be subjected to one or more additional chemical reactions to obtain one or more mercaptan derivatives with different functionalities, said chemical reactions being reactions well known to those skilled in the art.
- heteroatom in particular means an atom chosen from O, N, S, P and halogens.
- unsaturated hydrocarbon chain means a hydrocarbon chain comprising at least one double or one triple bond between two carbon atoms.
- Ri and R 7 are a hydrogen atom or a hydrocarbon chain, saturated or unsaturated, linear, branched or cyclic, aromatic or not, of 1 to 20 carbon atoms and possibly comprising one or more heteroatoms;
- R 2 is:
- R 3 being a hydrogen atom or a hydrocarbon chain, saturated or unsaturated, linear, branched or cyclic, aromatic or not, of 1 to 20 carbon atoms and possibly comprising one or more heteroatoms,
- -NR4R5, R4 and R 5 identical or different, being a hydrogen atom or a hydrocarbon chain, saturated or unsaturated, linear, branched or cyclic, aromatic or not, of 1 to 20 carbon atoms and possibly include one or more heteroatoms; n is equal to 1 or 2; and * represents an asymmetric carbon.
- mercaptans are said to be functionalized because in addition to the —SH chemical function, they also comprise at least one —NR 1 R 7 function of the amine type.
- n is equal to 2.
- R 2 is -OR 3 with R 3 as defined above.
- R 3 can in particular be a hydrogen atom or a saturated hydrocarbon chain, linear or branched, of 1 to 10 carbon atoms, preferably of 1 to 5 carbon atoms.
- R 3 is H.
- Ri and R 7 which are identical or different, are a hydrogen atom or a hydrocarbon chain, saturated, linear or branched, of 1 to 10 carbon atoms, preferably of 1 to 5 carbon atoms.
- Ri and R ? are H.
- the functionalized mercaptans of formula (I) can be chosen from the group consisting of homocysteine, cysteine and their derivatives.
- the functionalized mercaptans of formula (I) are L-homocysteine and L-cysteine.
- a preferred functionalized mercaptan of formula (I) is homocysteine, and more particularly L-homocysteine of the following formula:
- n is equal to 2
- R 2 is -OR 3 with R 3 is H and Ri and R ? are H.
- the functionalized mercaptans of formula (I) are chiral compounds. They can be obtained in pure enantiomeric form by the process according to the invention. In the present description, when the enantiomeric form is not specified, the compound is understood whatever its enantiomeric form.
- the reaction mixture at the end of step c) does not comprise any sulphide or polysulphide and in particular no sulphide or polysulphide corresponding to the functionalized mercaptan of formula (I) obtained.
- the reaction mixture at the end of step c) comprises less than 10%, preferably less than 5% molar sulphides and polysulphides with respect to the total number of moles of compound of formula (II) converted into compound of formula (I).
- sulfide is meant in particular the sulfide corresponding to the compound of formula (I) which is itself of the following formula (III):
- polysulphide is understood in particular to mean the polysulphide corresponding to the compound of formula
- n is equal to 2 (which corresponds to a disulphide).
- reaction mixture at the end of step c) does not comprise L-homocysteine sulphide or L-homocysteine when the compound of formula (I) is L-homocysteine.
- a functionalized mercaptan of formula (I ) as defined below and a compound of formula (V) GH with G as defined above i.e., a compound of the type: (i') R 6 -C(0)-OH, (ii') (R 7 0)(R 8 0)-P(O)-OH, or (iii') R 9 0- S0 2 -OH; with R 6 , R 7 , Rs and R 9 as defined below.
- R 6 , R 7 , Rs and R 9 as defined below.
- (II) is O-acetyl-L-homoserine, we get L-homocysteine and acetic acid.
- the compounds of formula (V) may be responsible for the acidification of the reaction mixture during step c). Also, it is possible to maintain the pH of the reaction mixture between 4 and 9, for example between 5 and 8, preferably between 6 and 7.5, and more particularly between 6.2 and 7.2, in particular during the step c) as mentioned above and in particular by adding a base as defined above.
- the present invention can be carried out in the presence of a sulphhydrate and/or sulphide salt or in the presence of H 2 S (hydrogen sulphide).
- Said salt is generally supplied in the form of a solution, preferably aqueous.
- Said at least one sulfhydrate and/or sulfide salt may be chosen from the group consisting of: ammonium sulfhydrate, alkali metal sulfhydrates, alkaline-earth metal sulfides, alkali metal sulfides and alkaline-earth metal sulfides.
- alkali metals lithium, sodium, potassium, rubidium and cesium, preferably sodium and potassium.
- alkaline-earth metals beryllium, magnesium, calcium, strontium and barium, preferably calcium.
- said at least one sulphide salt and/or sulphide salt can be chosen from the group consisting of: ammonium sulphide NH 4 SH, sodium sulphide NaSH, potassium sulphide KSH, calcium sulphide Ca(SH) 2 , sodium sulfide Na 2 S, ammonium sulfide (NH 4 ) 2 S, potassium sulfide K 2 S and calcium sulfide CaS.
- the preferred sulphide is ammonium sulphide NH 4 SH.
- the ammonium released during the reaction can for example be reused as a source of nitrogen for the growth of microorganisms, in particular of microorganisms expressing or overexpressing sulfhydrylase.
- the microorganisms can be chosen from the group consisting of: cells of bacteria such as Escherichia coli, Bacillus sp., or Pseudomonas, cells of yeasts such as Saccharomyces cerevisiae or Pichia pastoris, cells of fungi such as Aspergillus niger, Penicillium funiculosum or Trichoderma reesei, insect cells such as Sf9 cells, or even mammalian (in particular human) cells such as HEK 293, PER-C6 or CHO cell lines.
- bacteria such as Escherichia coli, Bacillus sp., or Pseudomonas
- yeasts such as Saccharomyces cerevisiae or Pichia pastoris
- fungi such as Aspergillus niger, Penicillium funiculosum or Trichoderma reesei
- insect cells such as Sf9 cells
- mammalian (in particular human) cells such as
- bacterial cells More particularly, bacterial cells and even more preferably d ⁇ cells will be used. coli.
- R 7 and R 8 identical or different, being a proton, an alkali, an alkaline earth or an ammonium, preferably a proton or an alkali, and more particularly H + or Na + ;
- R 9 is chosen from a proton, an alkali, an alkaline earth or an ammonium, preferably a proton or an alkali, and more particularly an H + or Na + proton;
- G represents either R 6 -C(0)-0- or R 9 0-S0 2 -0-; preferably G is R 6 -C(0)-0-
- R 2 and R 13 are H.
- aromatic group is preferably meant the phenyl group.
- the compound of general formula (II) is in particular a derivative of serine (when n is equal to 1) or homoserine (when n is equal to 2), in particular L-serine or L-homoserine .
- It can for example be chosen from the group consisting of: O-phospho-L-homoserine, O-succinyl-L-homoserine, GO-acetyl-L-homoserine, GO-acetoacetyl-L-homoserine, O-propio-L-homoserine, GO-coumaroyl-L-homoserine, GO-malonyl-L-homoserine, GO-hydroxymethylglutaryl-L-homoserine, O-pimelyl-L-homoserine O-sulfato-L-homoserine , GO-phospho-L serine, GO-succinyl-L serine, GO ace
- O-phospho-L-homoserine O-succinyl-L-homoserine, O-acetyl-L-homoserine, I ⁇ - acetoacetyl-L-homoserine , O-propio-L-homoserine, O-coumaroyl-L-homoserine, I ⁇ -malonyl-L-homoserine, O-hydroxymethylglutaryl-L-homoserine, O-pimelyl-L-homoserine and l 'O-sulfato-L-homoserine.
- the compound of general formula (II) can be chosen from the group consisting of: O-phospho-L-homoserine, O-succinyl-L-homoserine, O-acetyl-L-homoserine, O -sulfato-L-homoserine and O-propio-L-homoserine.
- the compound of general formula (II) can be chosen from the group consisting of: O-phospho-L-homoserine, O-succinyl-L-homoserine, O-acetyl-L-homoserine.
- OAHS O-acetyl-L-homoserine
- They can be obtained by a fermentation process from a hydrocarbon source and nitrogen, for example as described in application WO 2008/013432.
- renewable raw material can be chosen from glucose, sucrose, starch, molasses, glycerol, bioethanol, preferably glucose.
- L-serine derivatives can also be produced from the acetylation of L-serine, as L-serine can itself be obtained by fermentation of a renewable raw material.
- the renewable raw material can be chosen from glucose, sucrose, starch, molasses, glycerol, bioethanol, preferably glucose.
- L-homoserine derivatives can also be produced from the acetylation of L-homoserine, L-homoserine, which itself can be obtained by fermentation of a renewable raw material.
- the renewable raw material can be chosen from glucose, sucrose, starch, molasses, glycerol, bioethanol, preferably glucose.
- the reaction between said at least one compound of formula (II) and said at least one sulphide and/or sulphide salt as defined above or H S is carried out in the presence of at least one enzyme chosen from sulfhydrylases, preferably a sulfhydrylase associated with said compound of formula (II).
- sulfhydrylases preferably a sulfhydrylase associated with said compound of formula (II).
- the sulfhydrylase associated with a compound of formula (II) is easily identifiable because it shares the same name, for example O-acetyl-L-homoserine sulfhydrylase (OAHS Sulfhydrylase) is associated with O-acetyl-L-homoserine.
- the sulfhydrylase makes it possible in particular to catalyze the reaction between said compound of formula (II) and said salt or H 2 S.
- catalyst generally means a substance accelerating a reaction and which is found unchanged at the end of this reaction.
- the sulfhydrylase, and optionally its cofactor can be used in a catalytic amount.
- catalytic amount is meant in particular an amount sufficient to catalyze a reaction. More particularly, a reactant used in a catalytic quantity is used in a smaller quantity, for example between about 0.01% and 20% by weight, limits included, relative to the quantity by weight of a reactant used in a stoichiometric proportion.
- Said sulfhydrylase enzyme preferably belongs to the class of transferases, in particular designated by the nomenclature EC 2.X.X.XX (or denoted EC 2).
- the EC nomenclature for “Enzyme Commission numbers” is widely used and can be found at https://enzyme.expasy.org/.
- said enzyme is chosen from sulfhydrylases of class EC 2.5.X.XX (or denoted EC 2.5.), ie transferases which transfer an alkyl or aryl group other than a methyl group.
- the sulfhydrylases are in particular of class EC 2.5.1.XX (with XX which varies according to the substrate of the enzyme).
- O-acetylhomoserine sulfhydrylase is of the EC 2.5.1.49 type.
- - GO-phosphoserine sulfhydrylase is EC 2.5.1.65 type.
- O-succinylhomoserine sulfhydrylase is of type EC 2.5.1.49.
- O-acetyl-L-homoserine sulfhydrylase is of type EC 2.5.1.49.
- - GO-phospho-L-serine sulfhydrylase is of the EC 2.5.1.65 type.
- O-succinyl-L-homoserine sulfhydrylase is of type EC 2.5.1.49.
- the sulfhydrylase used can be chosen from O-phospho-L-homoserine sulfhydrylase, GO-succinyl-L-homoserine sulfhydrylase, O-acetyl-L-homoserine sulfhydrylase, GO-acetoacetyl-L-homoserine sulfhydrylase, GO-propio-L-homoserine sulfhydrylase, GO-coumaroyl-L-homoserine sulfhydrylase, GO -malonyl-L-homoserine sulfhydrylase, GO-hydroxymethylglutaryl-L-homoserine sulfhydrylase, O-pimelyl-L-homoserine sulfhydrylase, GO-s
- the sulfhydrylase used can be chosen from O-phospho-L-homoserine sulfhydrylase, O-succinyl-L-homoserine sulfhydrylase, O-acetyl-L-homoserine sulfhydrylase, O-acetoacetyl-L -homoserine sulfhydrylase, O-propio-L-homoserine sulfhydrylase, GO-coumaroyl-L-homoserine sulfhydrylase, O-malonyl-L-homoserine sulfhydrylase, GO-hydroxymethylglutaryl-L-homoserine sulfhydrylase, O-pimelyl- L-homoserine sulfhydrylase, GO-sulfato-L-homoserine sulfhydrylase.
- the sulfhydrylase can be chosen from O-phospho-L-homoserine sulfhydrylase, GO-succinyl-L-homoserine sulfhydrylase, O-acetyl-L-homoserine sulfhydrylase, O-sulfato-L-homoserine sulfhydrylase and O-propio-L-homoserine sulfhydrylase.
- the sulfhydrylase can be selected from GO-phospho-L-homoserine sulfhydrylase, GO-succinyl-L-homoserine sulfhydrylase and O-acetyl-L-homoserine sulfhydrylase.
- the enzyme is O-acetyl-L-homoserine sulfhydrylase (OAHS Sulfhydrylase).
- Said sulfhydrylase and in particular O-acetyl-L-homoserine sulfhydrylase, can come from or be derived from the following bacterial strains: Pseudomonas sp., Chromobacterium sp., Leptospira sp. or Hyphomonas sp..
- Sulfhydrylases can function, as well known to those skilled in the art, in the presence of a cofactor such as pyridoxal-5'-phosphate (also called PLP) or one of its analogues, preferably pyridoxal-5 '-phosphate.
- a cofactor such as pyridoxal-5'-phosphate (also called PLP) or one of its analogues, preferably pyridoxal-5 '-phosphate.
- a sulfhydrylase cofactor can be added to the reaction mixture.
- a sulfhydrylase cofactor for example pyridoxal-5'-phosphate
- step c) can be carried out in aqueous solution
- the enzyme and optionally its cofactor can be dissolved beforehand in water before being added to said solution.
- cells for example bacterial or other, can produce or even overproduce said cofactor at the same time as they express or overexpress the sulfhydrylase enzyme so as to avoid a step of supplementing said cofactor.
- the sulfhydrylase, and optionally its cofactor are:
- the isolation and/or purification of said enzyme produced can be carried out by any means known to those skilled in the art. It may be, for example, a technique chosen from electrophoresis, molecular sieving, ultracentrifugation, differential precipitation, for example with ammonium sulphate, ultrafiltration, membrane or gel filtration, exchange of ions, a separation by hydrophobic interactions, or an affinity chromatography, for example of the IMAC type.
- the enzyme of interest may or may not be overexpressed in said cells, hereinafter called host cells.
- the host cell can be any suitable host for the production of the enzyme of interest from the expression of the corresponding coding gene. This gene can then be found either in the host genome or carried by an expression vector.
- the term "host cell” within the meaning of the present invention is a prokaryotic or eukaryotic cell.
- Host cells commonly used for the expression of recombinant or non-recombinant proteins include in particular bacterial cells such as Escherichia coli or Bacillus sp., or Pseudomonas, yeast cells such as Saccharomyces cerevisiae or Pichia pastoris, fungal cells such as Aspergillus niger, Penicillium funiculosum or Trichoderma reesei, insect cells such as Sf9 cells, or even mammalian (in particular human) cells such as HEK 293, PER-C6 or CHO cell lines.
- the enzyme of interest and optionally the cofactor are expressed in the bacterium Escherichia coli.
- the enzyme of interest is expressed within a strain of Escherichia coli such as for example Escherichia coli BL21 (DE3).
- the cell lysate can be obtained using various known techniques such as sonication, pressure (French press), via the use of chemical agents (eg xylene, triton) etc...
- the lysate obtained corresponds to a crude extract crushed cells.
- the amount of biomass expressing the sulfhydrylase enzyme relative to the mass of the compound of formula (II) is between 0.1% and 10% by weight, of preferably between 1% and 5% by weight, and/or the amount of cofactor relative to the compound of formula (II) is between 0.1% and 10% by weight, preferably between 0.5% and 5% by weight, terminals included.
- the reaction mixture may also include:
- solvents chosen from water, buffers such as phosphate buffers, Tris-HCl, Tris-base, ammonium bicarbonate, ammonium acetate, HEPES (4-(2-hydroxyethyl)-1 acid piperazine ethane sulfonic), CHES (N-cyclohexyl-2-aminoethane sulfonic acid), or salts such as sodium chloride, potassium chloride, or mixtures thereof;
- buffers such as phosphate buffers, Tris-HCl, Tris-base, ammonium bicarbonate, ammonium acetate, HEPES (4-(2-hydroxyethyl)-1 acid piperazine ethane sulfonic), CHES (N-cyclohexyl-2-aminoethane sulfonic acid), or salts such as sodium chloride, potassium chloride, or mixtures thereof;
- additives such as surfactants, in particular to promote the solubility of one or more reagent(s) or substrate(s).
- step c) The various components which can be used for the reaction of step c) above are easily accessible commercially or can be prepared according to techniques well known to those skilled in the art. These different elements can be in solid, liquid or gaseous form and can very advantageously be dissolved or dissolved in water or any other solvent to be used in the process of the invention.
- the enzymes used can also be grafted onto a support (case of supported enzymes).
- said compound of formula (II) is O-acetyl-L-homoserine
- the enzyme used is GO-acetyl-L-homoserine sulfhydrylase
- the functionalized mercaptan of formula (I) obtained is L-homocysteine.
- said compound of formula (II) is O-acetyl-L-homoserine
- the salt is ammonium sulfhydrate
- the enzyme used is O-acetyl-L-homoserine sulfhydrylase
- the functionalized mercaptan of formula (I) obtained is L-homocysteine.
- the present invention also relates to a composition, preferably an aqueous solution, comprising: a compound of formula (II) as defined above; a sulfhydrylase, preferably a sulfhydrylase associated with the compound of formula (II), as defined above; and a hydrosulfide salt and/or a sulphide salt as defined above or excess HS, preferably excess NH 4 SH.
- said composition comprises: O-acetyl-L-homoserine; O-acetyl-L-homoserine sulfhydrylase; and excess NH 4 SH OR H 2 S.
- composition corresponds in particular to the reaction mixture as defined above.
- the conditions, characteristics and optional additional components are the same as those defined for the reaction mixture as defined above.
- the composition according to the invention does not comprise dissolved oxygen.
- the sulphide and/or sulphide salt or the H 2 S is in excess, preferably in molar excess, relative to the compound of formula (II).
- the sulphide and/or sulphide salt or the H 2 S can therefore be in an over-stoichiometric quantity with respect to the quantity of the compound of formula (II).
- the molar ratio [sulfhydrate salt and/or sulfide salt]/[compound of formula (II)] or H 2 S/compound of formula (II) is between 1.5 and 10, preferentially between 2 and 8, for example between 3.5 and 8, and even more preferably between 3.5 and 5, limits included.
- the composition may also comprise a sulfhydrylase cofactor as defined above.
- composition according to the invention allows the implementation of the method according to the invention.
- O-acetyl-L-homoserine was synthesized from L-homoserine and acetic anhydride according to the protocol described in the work of Sadamu Nagai, “Synthesis of O-acetyl-L-homoserine”, internationale Press, ( 1971), vol.17, p. 423-424.
- the analyzes by potentiometry, HPLC and NMR show a progressive disappearance of the reagents (OAHS and NaSH) and the progressive appearance of several products over time.
- the compounds thus formed are mainly:
- the molar selectivities with respect to the transformed OAHS obtained are as follows:
- homocysteine sulphide L-homolantionine / 4,4'-sulfanediylbis(2-aminobutanoic) acid
- homocystine disulphide / L-4,4'-Dithiobis(2-aminobutanoic) acid
- O-acetyl-L-homoserine was synthesized from L-homoserine and acetic anhydride according to the protocol described in the work of Sadamu Nagai, “Synthesis of O-acetyl-L-homoserine”, internationale Press, ( 1971), vol.17, p. 423-424.
- homocysteine sulphide (L-homolantionine) is not formed, because it is not detectable in the final reaction medium, even in trace amounts.
- O-acetyl-L-homoserine was synthesized from L-homoserine and acetic anhydride according to the protocol described in the work of Sadamu Nagai, “Synthesis of O-acetyl-L-homoserine”, internationale Press, ( 1971), vol.17, p. 423-424.
- the OAHS, NaSH and OAHS sulfhydrylase solutions and the water are previously degassed separately by nitrogen sparging at the reaction temperature (before mixing) to eliminate the presence of dissolved oxygen.
- the reactor is also inerted under dinitrogen.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Zoology (AREA)
- Engineering & Computer Science (AREA)
- Wood Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Compounds Of Unknown Constitution (AREA)
- Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
Abstract
Description
Claims
Priority Applications (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2023504118A JP2023534544A (ja) | 2020-07-20 | 2021-07-13 | 官能化メルカプタンを合成するための改善された方法 |
KR1020237005379A KR20230038768A (ko) | 2020-07-20 | 2021-07-13 | 작용성화된 메르캅탄을 합성하기 위한 개선된 방법 |
EP21749242.0A EP4182300A1 (fr) | 2020-07-20 | 2021-07-13 | Procede ameliore de synthese de mercaptans fonctionnalises |
US18/005,306 US20230295080A1 (en) | 2020-07-20 | 2021-07-13 | Improved process for synthesizing functionalized mercaptans |
CN202180059319.XA CN116157385A (zh) | 2020-07-20 | 2021-07-13 | 用于合成官能化的硫醇的改进工艺 |
BR112023000600A BR112023000600A2 (pt) | 2020-07-20 | 2021-07-13 | Método melhorado de síntese de mercaptanos funcionalizados |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR2007577A FR3112549A1 (fr) | 2020-07-20 | 2020-07-20 | Procede ameliore de synthese de mercaptans fonctionnalises |
FRFR2007577 | 2020-07-20 | ||
FR2012669A FR3112548B1 (fr) | 2020-07-20 | 2020-12-04 | Procede ameliore de synthese de mercaptans fonctionnalises |
FRFR2012669 | 2020-12-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022018352A1 true WO2022018352A1 (fr) | 2022-01-27 |
Family
ID=72885747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2021/051300 WO2022018352A1 (fr) | 2020-07-20 | 2021-07-13 | Procede ameliore de synthese de mercaptans fonctionnalises |
Country Status (10)
Country | Link |
---|---|
US (1) | US20230295080A1 (fr) |
EP (1) | EP4182300A1 (fr) |
JP (1) | JP2023534544A (fr) |
KR (1) | KR20230038768A (fr) |
CN (1) | CN116157385A (fr) |
BR (1) | BR112023000600A2 (fr) |
CL (1) | CL2023000162A1 (fr) |
FR (2) | FR3112549A1 (fr) |
TW (1) | TWI803906B (fr) |
WO (1) | WO2022018352A1 (fr) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008013432A1 (fr) | 2006-07-28 | 2008-01-31 | Cj Cheiljedang Corporation | Micro-organisme produisant un précurseur de l-méthionine et procédé de production de l-méthionine et d'acide organique à partir du précurseur de l-méthionine |
WO2012053777A2 (fr) | 2010-10-20 | 2012-04-26 | Cj Cheiljedang Corporation | Mutants de o-phosphosérine sulfhydrylase et procédé de production de cystéine les utilisant |
EP3181685A1 (fr) * | 2014-08-12 | 2017-06-21 | Cj Cheiljedang Corporation | Micro-organisme producteur d'o-phosphosérine et procédé de production d'o-phosphosérine ou de l-cystéine à l'aide de celui-ci |
-
2020
- 2020-07-20 FR FR2007577A patent/FR3112549A1/fr active Pending
- 2020-12-04 FR FR2012669A patent/FR3112548B1/fr active Active
-
2021
- 2021-07-13 BR BR112023000600A patent/BR112023000600A2/pt unknown
- 2021-07-13 US US18/005,306 patent/US20230295080A1/en active Pending
- 2021-07-13 KR KR1020237005379A patent/KR20230038768A/ko unknown
- 2021-07-13 JP JP2023504118A patent/JP2023534544A/ja active Pending
- 2021-07-13 CN CN202180059319.XA patent/CN116157385A/zh active Pending
- 2021-07-13 WO PCT/FR2021/051300 patent/WO2022018352A1/fr active Application Filing
- 2021-07-13 EP EP21749242.0A patent/EP4182300A1/fr active Pending
- 2021-07-19 TW TW110126356A patent/TWI803906B/zh active
-
2023
- 2023-01-17 CL CL2023000162A patent/CL2023000162A1/es unknown
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008013432A1 (fr) | 2006-07-28 | 2008-01-31 | Cj Cheiljedang Corporation | Micro-organisme produisant un précurseur de l-méthionine et procédé de production de l-méthionine et d'acide organique à partir du précurseur de l-méthionine |
WO2012053777A2 (fr) | 2010-10-20 | 2012-04-26 | Cj Cheiljedang Corporation | Mutants de o-phosphosérine sulfhydrylase et procédé de production de cystéine les utilisant |
EP3181685A1 (fr) * | 2014-08-12 | 2017-06-21 | Cj Cheiljedang Corporation | Micro-organisme producteur d'o-phosphosérine et procédé de production d'o-phosphosérine ou de l-cystéine à l'aide de celui-ci |
Non-Patent Citations (4)
Title |
---|
GROMAN ET AL., PROC. NAT. ACAD. SCI. USA, vol. 69, no. 11, pages 3297 - 3300 |
MAIER T., NATURE BIOTECHNOLOGY, vol. 21, 2003, pages 422 - 427 |
SADAMU NAGAI: "Synthesis of O-acetyl-L-homoserine", vol. 17, 1971, ACADEMIC PRESS, pages: 423 - 424 |
WHITE R H ED - LILLIG C H ET AL: "The biosynthesis of cysteine and homocysteine in Methanococcus jannaschii", BIOCHIMICA ET BIOPHYSICA ACTA, ELSEVIER, AMSTERDAM, NL, vol. 1624, no. 1-3, 5 December 2003 (2003-12-05), pages 46 - 53, XP004475870, ISSN: 0304-4165, DOI: 10.1016/J.BBAGEN.2003.09.005 * |
Also Published As
Publication number | Publication date |
---|---|
TWI803906B (zh) | 2023-06-01 |
BR112023000600A2 (pt) | 2023-01-31 |
CN116157385A (zh) | 2023-05-23 |
FR3112548B1 (fr) | 2024-05-17 |
KR20230038768A (ko) | 2023-03-21 |
CL2023000162A1 (es) | 2023-07-28 |
TW202212323A (zh) | 2022-04-01 |
FR3112549A1 (fr) | 2022-01-21 |
JP2023534544A (ja) | 2023-08-09 |
US20230295080A1 (en) | 2023-09-21 |
EP4182300A1 (fr) | 2023-05-24 |
FR3112548A1 (fr) | 2022-01-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3356325B1 (fr) | Procédé de production de mercaptans par hydrogénolyse enzymatique de disulfures | |
EP2890674B1 (fr) | Préparation de disulfures symétriques et dissymétriques par distillation réactive de mélanges de disulfures | |
EP4182300A1 (fr) | Procede ameliore de synthese de mercaptans fonctionnalises | |
EP4041708A1 (fr) | Procede de preparation de mercaptans par sulfhydrolyse de sulfures | |
CH666695A5 (fr) | Procede enzymatique de preparation de l-amino acides contenant du soufre. | |
EP4255887A1 (fr) | Procede de synthese de mercaptans fonctionnalises sous pression d'h2s | |
US10563236B2 (en) | Method for producing L-methionine | |
EP3356326B1 (fr) | Procédé de production de mercaptans par hydrogénolyse enzymatique de disulfures à l'aide d'hydrogène | |
WO2018122510A1 (fr) | Procédé de synthèse de dithiocarbamates cycliques fonctionnalisés | |
EP3562949A1 (fr) | Procédé de synthèse de polysulfures fonctionnalisés | |
EP4118223A1 (fr) | Procédé chimio-enzymatique de coproduction d'un disulfure et d'un sulfoxyde ou d'une sulfone | |
FR3041658A1 (fr) | Procede de production de l-methionine | |
EP1666458A1 (fr) | Derive optiquement actif de 3,3-dithiobis (acide 2-amino-2-methlypropionique) et procede de production d'un derive optiquement actif d'acide 2-amino-3-mercapto-2-methyl-propionique |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21749242 Country of ref document: EP Kind code of ref document: A1 |
|
ENP | Entry into the national phase |
Ref document number: 2023504118 Country of ref document: JP Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: 112023000600 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: 112023000600 Country of ref document: BR Kind code of ref document: A2 Effective date: 20230112 |
|
ENP | Entry into the national phase |
Ref document number: 20237005379 Country of ref document: KR Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021749242 Country of ref document: EP Effective date: 20230220 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 523442166 Country of ref document: SA |